3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Unknown
30
Completed
27
Recruiting
7
Not yet recruiting
5
Active not recruiting
4
Terminated
2
Suspended
2
Withdrawn
1
Sponsor Class
OTHER
309
INDUSTRY
134
NIH
23
NETWORK
19
OTHER_GOV
2
FED
1
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
2
Head & Neck
1
Conditions
Breast Neoplasms
6
Colorectal Neoplasms
4
Prostatic Neoplasms
3
Pancreatic Neoplasms
3
Neoplasms
3
Stomach Neoplasms
2
Small Cell Lung Carcinoma
2
Sarcoma, Kaposi
2
Rectal Neoplasms
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Lung Neoplasms
2
Inflammatory Bowel Diseases
2
Head and Neck Neoplasms
2
HIV Infections
2
Colonic Neoplasms
2
Carcinoma, Renal Cell
2
Uterine Cervical Neoplasms
1
Urinary Tract Infections
1
Triple Negative Breast Neoplasms
1
Tongue Neoplasms
1
Stomatitis
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumor
1
Renal Insufficiency
1
Recurrence
1
Radiation Injuries
1
Prostatic Diseases
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Postoperative Complications
1
Interventions
Pemetrexed
1
Gemcitabine
1
Gefitinib
1
Docetaxel
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Terminated
×
OTHER_GOV
×
Lung Neoplasms
×
Clear all
NCT01405846
2016-08-19
TIDAL1
Papworth Hospital NHS Foundation Trust
Phase 2
Terminated
32 enrolled
NCT01356368
2014-01-22
Customizing
National Guard Health Affairs
Phase 2
Terminated
3 enrolled